A new treatment option in asthma management.
For the first time in 20 years a new therapeutic option in asthma management has emerged. Christine Fehrenbach discusses the role of leukotriene receptor antagonists in asthma care.
Portsmouth Trust Hospitals.
C
C
Fehrenbach
D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology*; D002648:Child; D006801:Humans; D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000627:therapeutic use*
D018927:Anti-Asthmatic Agents; D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds; C062735:zafirlukast